Today: 12 March 2026

Marcin Frąckiewicz

CEO of TS2 Space and founder of TS2.tech. Expert in satellites, telecommunications, and emerging technologies, covering trends in space, AI, and connectivity.

Nvidia’s AI Empire Unleashed: Mini Supercomputers, Mega-Deals and a Global Chip Arms Race

Nvidia’s AI Empire Unleashed: Mini Supercomputers, Mega-Deals and a Global Chip Arms Race

Nvidia delivered its first DGX Spark petaflop AI supercomputer to SpaceX, fitting data-center power into a portable device. The company struck a $100 billion deal with OpenAI for priority chip access and 10 GW of new AI supercomputing, while OpenAI also agreed to buy 6 GW of AMD chips and take a stake in AMD. U.S. officials eased export rules, allowing over $10 billion in Nvidia AI chips to reach the UAE for American-run cloud centers.
RTX Stock Defies Market Slump as Engine ‘Game-Changer’ and Defense Deals Fuel Rally

RTX Stock Defies Market Slump as Engine ‘Game-Changer’ and Defense Deals Fuel Rally

RTX shares closed at $157.80 on Oct. 17, up 0.5% as the S&P 500 fell. Pratt & Whitney’s new GTF Advantage engine won EASA certification, with commercial entry expected in 2026. Raytheon broke ground on a $53 million expansion to boost LTAMDS radar production amid rising global demand. RTX reports Q3 earnings Oct. 21, with analysts expecting $1.42 EPS on $21.5 billion revenue.
IBM Stock Soars on Quantum Breakthrough and AI Revival – Key Updates (Sept 25, 2025)

IBM Stock Hits Multi-Year High on AI & Quantum Hype – Can the Rally Last?

IBM shares traded near $276 on Oct. 16, up 28% year-to-date and close to all-time highs. Recent AI and quantum partnerships, along with strong Q2 results—$16.98 billion revenue and $2.80 EPS—have fueled the rally. Analysts remain cautious, with a consensus “Hold” rating and a $280 price target. Q3 earnings are due Oct. 22.
Cisco’s $2B AI Windfall: New Tech, Stock Surge & What’s Next for CSCO

Cisco Rides AI Wave as Stock Nears Year-High – What’s Next for CSCO?

Cisco shares traded near $69 on Oct. 17, 2025, close to their 52-week high of $72.55 and up about 30% from a year ago. The company beat earnings expectations with $0.99 EPS and $14.67 billion in revenue, driven by strong AI-related orders and new chip launches. Cisco raised its dividend to $0.41 per share. Wall Street’s consensus rates the stock a “Moderate Buy” with a $74–75 price target.
Alibaba Stock Soars on AI Frenzy – Can the Rally Last?

Alibaba’s 2025 Comeback: AI Ambitions Fuel BABA Stock Rally – Will It Last?

Alibaba’s U.S. shares closed near $167 on Oct. 17 after rebounding from early losses, holding an 85% year-to-date gain and trading at four-year highs. The move followed a one-day 8% surge in September and outperformed a 4% drop in Hong Kong shares. Cloud revenue jumped 26% last quarter on AI demand, but heavy investment cut margins. Wall Street remains bullish, with most analysts rating BABA a “Buy.”
Oscar Health Stock Skyrockets on AI-Fuelled Growth Plans – Analysts Warn of ACA Risks

Oscar Health Stock Skyrockets on AI-Fuelled Growth Plans – Analysts Warn of ACA Risks

Oscar Health shares jumped 11% to $21.50 on Oct. 3, 2025, and traded near $21.76 on Oct. 14, up roughly 40% year-to-date. The company announced a $410 million convertible debt offering to fund AI initiatives and launched a new employer health plan with Hy-Vee. Q2 revenue rose to about $2.9 billion, but net losses widened to $228 million. Analysts remain bearish, with an average price target near $12.
Reddit’s Stock Explodes! 78% Revenue Surge, Google AI Deal Talks & 70% Rally 🔥

Reddit Stock Rockets and Slumps: RDDT’s Wild Ride in 2025

Reddit shares traded around $190 on Oct. 17, down 4.3% for the day and off sharply from a mid-September record near $283. The stock remains up about 244% year-to-date and over 600% since its March 2024 IPO. Q2 revenue jumped 78% to $500 million, with net income at $89 million. Analyst consensus rates the stock a “Moderate Buy,” with a 12-month price target averaging $202.
17 October 2025
Gilead Sciences (GILD) Stock Soars on Patent Victory, HIV Breakthroughs, and Analyst Upgrades

Gilead Sciences (GILD) Stock Soars on Patent Victory, HIV Breakthroughs, and Analyst Upgrades

Gilead Sciences shares rose to $123 on October 17, 2025, up nearly 40% from a year ago, lifting its market value to about $150 billion. The company settled U.S. patent litigation over HIV drug Biktarvy, blocking generics until 2036. Its new HIV prevention shot Yeztugo is seeing strong uptake, and Moody’s raised Gilead’s outlook to “Positive.” Gilead also announced a $1.5 billion cell therapy deal with Pregene.
Rekor Systems (REKR) Stock Rockets 73% on AI-Powered Roadway Tech Breakthroughs

Rekor Systems (REKR) Stock Rockets 73% on AI-Powered Roadway Tech Breakthroughs

Rekor Systems shares surged about 20% to $3.17 on Oct. 17, extending a 73% rally over the past month after the company previewed record Q3 revenue and major new contracts. Rekor won a $50M+ Georgia DOT deal, deployments with Caltrans and TxDOT, and a $1M South Carolina order. The price-to-sales ratio now matches the industry median as investors anticipate 19% revenue growth next year.
Liberty Energy’s Rollercoaster: LBRT Surges on Earnings Despite Oilfield Headwinds

Liberty Energy’s Rollercoaster: LBRT Surges on Earnings Despite Oilfield Headwinds

Liberty Energy shares jumped over 20% intraday on October 17 after reporting Q3 revenue of $947 million, down 17% year-over-year, and an adjusted net loss of $0.06 per share. Despite the rebound, LBRT remains about 40% lower year-to-date, closing at $11.94 on October 16. The company raised its quarterly dividend by 13% to $0.09 per share. Analyst price targets cluster around $13–$15 for the next year.
Bitcoin Crash Conspiracy? New Evidence Exposes Massive Crypto Market Manipulation

Bitcoin Crash Conspiracy? New Evidence Exposes Massive Crypto Market Manipulation

Bitcoin and the crypto market plunged on Oct. 10–11, 2025, erasing over $19 billion in leveraged positions after President Trump announced 100% tariffs on Chinese goods. Bitcoin fell nearly 10%, Ethereum 20%, and some altcoins up to 40%. Major exchanges like Binance faced outages and accusations of profiting from liquidations. On-chain data showed whales moved large sums just before the crash, fueling manipulation suspicions.
Kezar Life Sciences Stock Soars 40% After FDA Setback Sparks Strategic Shake-Up

Kezar Life Sciences Stock Soars 40% After FDA Setback Sparks Strategic Shake-Up

Kezar Life Sciences said the FDA canceled a key meeting and imposed new trial demands for its lead drug zetomipzomib, delaying development by about two years. The company is now exploring a sale or merger and cutting costs. Shares jumped nearly 40% to $6 on Oct. 17. Kezar reported $90.2 million in cash as of Sept. 30 but faces higher expenses and extended a poison pill plan to 2026.
Disc Medicine (IRON) Stock Soars on FDA Fast-Track News as Analysts Boost Targets

Disc Medicine (IRON) Stock Soars on FDA Fast-Track News as Analysts Boost Targets

Disc Medicine shares jumped 25.5% to $93 on October 17, 2025, after the FDA granted a Commissioner’s National Priority Voucher for its lead drug, bitopertin. The company filed a New Drug Application for bitopertin in late September; with the voucher, an approval decision could come as soon as late December. Several analysts raised their price targets sharply following the FDA news.
17 October 2025
Nebius (NBIS) Stock Rockets on $17B Microsoft AI Deal – Explosive Growth & Outlook Revealed

Nebius Group (NBIS) Skyrockets 350% on AI Deal, Then Stumbles – What’s Next for This Cloud Newcomer?

Nebius Group (NASDAQ: NBIS) stock soared over 350% year-to-date, fueled by a $17.4 billion AI infrastructure deal with Microsoft in September that triggered a one-day 44% jump. Shares cooled to $114 on Oct. 17, down 7% amid heavy profit-taking. The company raised $1.3 billion recently to fund a $3 billion expansion of its AI cloud capacity. Q2 revenue surged 625% to $105.1 million, but Nebius remains unprofitable.
Salesforce (CRM) Stock Soars on $60B AI Bet – Can the Cloud Giant’s Rally Last?

Salesforce (CRM) Stock Soars on $60B AI Bet – Can the Cloud Giant’s Rally Last?

Salesforce shares jumped nearly 4% to around $245 Friday after the company raised its 2030 revenue target above $60 billion, beating Wall Street estimates. Despite the rally, CRM remains down about 29% in 2025, lagging major peers and indexes. The new forecast excludes an $8 billion Informatica deal aimed at boosting AI capabilities. Investors remain split, with analyst targets ranging from $221 to $405.
Newmont Stock Skyrockets as Gold Rally Hits Record Highs – Will the Boom Continue?

Newmont Stock Skyrockets on Gold Boom: Record Highs, $100 B Milestone & Bold Forecasts

Newmont Corporation shares surged nearly 15% this week, pushing its market value above $100 billion for the first time. The rally follows gold prices hitting record highs above $4,300 per ounce amid geopolitical tensions and Fed rate cut expectations. Major banks raised price targets, with Bank of America setting a $115 target on October 16. Newmont reports Q3 earnings October 23, with analysts forecasting a 58% profit jump.
17 October 2025
1 227 228 229 230 231 358

Stock Market Today

  • Wheat Prices Edge Higher Amid Tender Deals and Weather Outlook
    March 12, 2026, 2:09 AM EDT. Wheat futures in Chicago, Kansas City, and Minneapolis rose by 2 to 6 cents on Wednesday midday as the Southern Plains expect drier weather while the eastern U.S. and soft red winter wheat (SRW) regions forecast wetter conditions. Significant tender activity supported the gains, with South Korea purchasing 32,000 metric tons of U.S. wheat and Taiwan issuing a tender for 105,020 metric tons. French soft wheat stocks increased by 340,000 metric tons to 3.39 million metric tons. March wheat futures showed mixed results, reflecting ongoing market volatility in the grain sector. These developments underscore continued global demand and weather-driven supply concerns influencing wheat prices.

Latest article

Wall Street Feels the Heat (and Thrill): Fed Cuts, Tariffs & Mega-Mergers Set NYSE Buzz

Stock Market Today 12.03.2026

12 March 2026
LIVEMarkets rolling coverageStarted: March 12, 2026, 12:00 AM EDTUpdated: March 12, 2026, 2:14 AM EDT Wheat Prices Edge Higher Amid Tender Deals and Weather Outlook March 12, 2026, 2:09 AM EDT. Wheat futures in Chicago, Kansas City, and Minneapolis rose by 2 to 6 cents on Wednesday midday as the Southern Plains expect drier weather while the eastern U.S. and soft red winter wheat (SRW) regions forecast wetter conditions. Significant tender activity supported the gains, with South Korea purchasing 32,000 metric tons of U.S. wheat and Taiwan issuing a tender for 105,020 metric tons. French soft wheat stocks increased by
XRP Price Today: Ripple’s Australia License Push Keeps XRP Near $1.40

XRP Price Today: Ripple’s Australia License Push Keeps XRP Near $1.40

11 March 2026
XRP traded near $1.40, down 1.4% Wednesday, after Ripple announced plans to acquire BC Payments Australia to secure an Australian Financial Services Licence. The move comes as Australia tightens licensing rules for digital-asset firms. Broader crypto markets remained cautious amid concerns over oil prices, Iran, and U.S. inflation. Ripple’s deal is pending completion.
Natural Gas Price Today: Europe Gas Holds Firm as Brussels Weighs Cap After Qatar Shock

Natural Gas Price Today: Europe Gas Holds Firm as Brussels Weighs Cap After Qatar Shock

11 March 2026
European natural gas prices held near 48 euros per megawatt hour Wednesday as Shell declared force majeure on Qatari LNG cargoes, with disruptions expected to hit from April. Asia is bidding up for replacement fuel, while Brussels considers subsidies or a price cap. LNG Canada increased shipments, but analysts warn Europe’s gas storage could end March far below average if Qatari supply issues persist.
Go toTop